期刊文献+

重症多形红斑型药疹25例和中毒性表皮坏死松解症17例回顾性分析 被引量:8

A Retrospective Study on 25 Cases of Stevens Johnson Syndrome and 17 Cases of Toxic Epidermal Necrolysis
下载PDF
导出
摘要 对1990年12月~2013年4月本院收治的25例重症多形红斑(SJS)和17例中毒性表皮坏死松解症(TEN)患者的临床资料进行回顾性分析。探讨SJS和TEN的致敏因素、发生规律、临床特征和治疗措施。药物是引起SJS和TEN的最主要病因。致敏药物以抗菌药物为主(52.38%),其次是抗癫痫药(28.57%)。黏膜损害和肝功能损害是最常见的并发症。 SJS和TEN均系统应用糖皮质激素治疗,SJS组8例和TEN组4例给予激素联合人免疫球蛋白治疗。系统应用糖皮质激素尤其是联合人免疫球蛋白治疗SJS和TEN有效。 The clinical data of hospitalized patients of 25 cases of Stevens Johnson syndrome (SJS) and 17 cases of toxic epidermal necrolysis (TEN) were reviewed retrospectively from 1990 to 2013, to study the general patterns of the development of SJS and TEN, the clinical features and appropriate therapies. SJS and TEN had often been caused by drug reactions. The major sensitizing drugs were antibiotics (52.38%) and antiepileptics (28.57%). Hepatitis and mucosal damage were the most common organ damage in both SJS and TEN. Systemic corticosteroids were used in 25 cases of SJS and 17 cases of TEN, among which 8 cases of SJS and 4 cases of TEN were treated with immunoglobulin combined with corticosteroid. Systemic therapy with corticosteroids especially treated with combined therapy of immunoglobulin and corticosteroid have beneficial effects on SJS and TEN.
出处 《药学与临床研究》 2014年第6期539-541,共3页 Pharmaceutical and Clinical Research
关键词 重症多形红斑 中毒性表皮坏死松解症 回顾性分析 Stevens johnson syndrome Toxic epidermal necrolysis Retrospective study
  • 相关文献

参考文献17

  • 1Sharma VK, Sethuraman G. Adverse cutaneous reac- tions to drugs: An overview[J]. Postgrad Med, 1996, 42 (1): 15-22.
  • 2Leenutaphong V, Sivayathorn A, Suthipinittharm P, et al. Stevens -Johnson syndrome and toxic epidermal necrolysis in Thailand [J]. lnt J Dermatol, 1993, 32(6): 428-31.
  • 3陈金波,王宝玺,王宏伟,曾跃平,徐浩翔.Stevens—Johnson综合征及中毒性表皮坏死松解症61例回顾性分析[J].中华皮肤科杂志,2008,41(8):542-545. 被引量:19
  • 4French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding[J]. A llergol Int, 2006, 55(1): 9-16.
  • 5Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase in- hibitor abacavir[J]. Lancet, 2002, 359(9308): 727-32.
  • 6Chung WH, Hung SI, Chen YT. Human leukocyte antigens and drug hupersensitivity[J]. Curr Opin Allergy Clin Immunol, 2007, 7(4): 317-23.
  • 7Chung WH, Hung SI, Hong HS, et al. Medical genet- ics:a marker for Stevens-Johnson syndrome [J]. Nature, 2004, 428(6982): 486.
  • 8Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol [J]. Proc Naal Acad Scl USA, 2005, 102(11): 4134-9.
  • 9Chiu MLS, Hu M, Chang MM, et al. Association be- tween HLA-B*5801 allele and severe cutaneous ad- verse reactions with allopurinol in Han Ctlinese in Hong Kang[J]. Br J Dermatol, 2012, 167(1): 44-9.
  • 10Cao ZH, Wei ZY, Zhu QY, et al. HLA-B*5801 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allop- urinol in Han Chinese[J]. Pharmacogenomics, 2012, 13 (10): 1193-201.

二级参考文献26

  • 1French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int, 2006, 55( 1 ): 9-16.
  • 2Paquet P, Pierard GE, Quatresooz P. Novel treatments for druginduced toxic epidermal necrolysis (Lyell's syndrome ). hat Arch Allergy Immunol, 2005, 136(3 ): 205-216.
  • 3Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol, 2000, 115(2): 149-153.
  • 4Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science, 1998, 282(5388): 490-493.
  • 5Stella M, Clemente A, Bollero D, et al. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Bums, 2007, 33(4): 452-459.
  • 6Leenutaphong V, Sivayathorn A, Suthipinittharm P, et al. Stevens-Johnson syndrome and toxic epidermal neerolysis in Thailand[ J]. Int J Dermatol, 1993,32(6) :428-431.
  • 7Gareia-Doval I, Lecleach L, Bocquet H, et al. Toxic epi- dermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death ? [ J ]. Arch Dermatol, 2000,136 ( 3 ) : 323-327.
  • 8Pereira de Silva N, Piquioni P, Kochen S, et al. Risk fac- tors associated with DRESS syndrome produced by aro- matic and non-aromatic antipiletic drugs [ J ]. Eur J Clin Pharmacol,2011,67 (5) :463-470.
  • 9Borchers AT, Lee JL, Naguwa SM, et al. Stevens-johnson syndrome and toxic epidermal necrolysis [ J ]. Autoimmun Rev, 2008,7 ( 8 ) : 598 -605.
  • 10Harr T, French LE. Toxic epidermal necrolysis and Ste- vens-Johnson syndrome[ J]. Orphanet J Rare Dis,2010,5 (1) :39.

共引文献40

同被引文献75

  • 1李瑞珍,宋伟峰,刘杰.卡马西平致不良反应文献分析[J].中国药业,2005,14(5):57-58. 被引量:13
  • 2刘蓉,周东,陈芹.卡马西平引起重型药疹22例临床分析[J].四川医学,2006,27(7):711-713. 被引量:8
  • 3王萍,任榕娜.抗癫痫药物的毒副作用[J].国际内科学杂志,2007,34(2):91-94. 被引量:32
  • 4薛建健,王静,廖达林,倪铭孔,彭明.卡马西平致大疱性表皮松解症1例的护理[J].中国误诊学杂志,2007,7(12):2903-2903. 被引量:3
  • 5Digwood-Lettieri S, Reilly KJ, Haith LR Jr, et al. Levofloxacin- induced toxic epidermal neerolysis in an elderly patient[J]. Pharmacotherapy, 2002, 22(6): 789-793.
  • 6Islam AF, Rahman MS. Levofloxacin-induced fatal toxic epidermal necrolysis[J]. Ann Pharmacother, 2005, 39(6): 1136-1137.
  • 7Christie MJ, Wong K, Ting RH, et al. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure[J]. Ann Pharmacother, 2005, 39(5): 953-955.
  • 8Davila G, Ruiz-Hornillos J, Rojas P, et al. Toxic epidermal necrolysis induced by levofloxacin[J]. Ann Allergy Asthma Immunol, 2009, 102(5): 441-442.
  • 9Teo WL, Pang SM. Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immurtoglobulin[J]. Ann Acad Med Singapore, 2010, 39(8): 660-661.
  • 10Fernandez Arenas O, Lopez Lunar E, Gutierrez Garcia M, et al. Levofloxacin-related Stevens-Johnson syndrome[J]. Farm Hosp, 2012, 36(1): 53-55.

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部